Presentation TCT 2024 TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis Presenter: Wilbert Bor October 27, 2024
Presentation ESC 2024 Continuation versus Interruption of Oral Anticoagulation during TAVI Presenter: Dirk-Jan van Ginkel August 31, 2024
Presentation NY Valves 2024 Surgical Closure of the LAA: Patient Selection, Procedural Success, and Postprocedural Anticoagulation Strategies Presenter: Guido Ascione June 07, 2024
Presentation THT Abstracts 2024 Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone Presenter: Daniel Snyder March 05, 2024
Presentation CTO 2024 Using Platelet Function Testing to Guide Medical Management Following Complex Percutaneous Coronary Intervention in Patients Requiring Therapeutic Anticoagulation Presenter: Daniel J. Snyder February 03, 2024
Presentation AHA 2023 Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial Presenter: Nina Becher November 14, 2023
Presentation TCT 2023 Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials Presenter: Yousif Ahmad October 25, 2023
Presentation TCT 2023 TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography Presenter: Ting-Yu Wang October 25, 2023
Presentation ESC 2023 Post procedural anticoagulation after primary percutaneous coronary intervention for ST segment elevation myocardial infarction: a multicentre, randomised, double blind trial Presenter: Shaoping Nie August 28, 2023
Presentation EuroPCR 2023 Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial Presenter: Xavier Freixa May 17, 2023
Presentation CTO 2023 CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy? Presenter: Roxana Mehran February 24, 2023
Presentation TCT 2022 Anticoagulation for PE: When to Switch to DOACs? Presenter: Behnood Bikdeli September 19, 2022
Presentation TCT 2022 TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation Presenter: Norman Mangner September 19, 2022
Presentation TCT 2022 Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch? Presenter: Teresa Carman September 19, 2022
Presentation TCT 2022 TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation Presenter: Claudio Cigalini September 18, 2022
Presentation TCT 2022 Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond Presenter: Marc Bonaca September 17, 2022
Presentation TCT 2022 2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents Presenter: Craig Beavers September 16, 2022
Presentation TCT 2021 Oral Anticoagulation Should Be the Default Strategy After LAAC Presenter: Matthew J. Price November 06, 2021
Presentation TCT 2021 Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond Presenter: Connie Hess November 06, 2021